5th Annual Bio Manufacturing Summit

May 23-24, 2016

This exciting and interactive workshop-style event focused on: The Future of Biomanufacturing.

  • Location: UMass Lowell Inn & Conference Center, Lowell, MA
  • Hosted by: the Biomanufacturing Science and Technology Consortium (BSTC), Massachusetts BioManufacturing Center (MBMC), and the University of Massachusetts, Lowell

Distinguished thought leaders across four sessions presented the changing landscape of biomanufacturing:

  1. Cell & Gene Therapeutics, Vaccines;
  2. Protein Therapeutics & Analytical
  3. Regulatory Sciences, Standardization and Workforce Development
  4. Protein Therapeutics & Formulation

It was a chance to interact with professionals and leaders of the biopharmaceutical industry on current biomanufacturing challenges and breakthrough technologies.

  • Emerging Technology and New Therapeutics
  • Regulatory Sciences and Standardization
  • Industry Practices and New Trends in PAT, QbD, Quality Metrics, and Process Validation
  • Integrated Continuous Manufacturing Systems
  • Synthetic Biology in Biomanufacturing

It was also a chance to network with professionals from major biopharmaceutical manufacturers and a variety of technology providers.

You will need Adobe Acrobat Reader to view any pdf files. It can be download for free from the Adobe website.

Plenary Speakers

  • Tim Charlebois, Ph.D., Vice President, BioTherapeutics Pharmaceutical Sciences, Technology & Innovation, Pfizer
  • Larry Lee, Ph.D., Acting Director, Food and Drug Administration, Center for Drug Evaluation and Research, Office of Pharmaceutical Quality, Immediate Office

Session Presenters

  • Barbara Thorne, Ph.D., Consultant, Thorne Bio-Consulting LLC
  • David Knop, Ph.D., Executive Director, Process Development, Applied Genetic Technologies Corporation (AGTC)
  • Erika M. McAfee, M.S., Scientist, Lonza Walkersville
  • Krishnendu Roy, Ph.D., Professor of Biomedical Engineering, Georgia Tech
  • Sadettin S. Ozturk, Ph.D., Deputy Director, Process Development, MassBiologics
  • Wei-Shou Hu, Ph.D., Professor of Chemical Engineering, University of Minnesota
  • Anthony J. Sinskey, Ph.D., Professor of Microbiology, Massachusetts Institute of Technology
  • Alex Lazar, Ph.D., Head of Analytical and Pharmaceutical Sciences, ImmunoGen, Inc.
  • John C. Gebler, Ph.D., Director of Biopharma Business Development, Waters Corp
  • Patrick Swann, Ph.D., Senior Director, Biogen, Inc.
  • Michael J. Betenbaugh, Ph.D., Professor of Chemical and Biomolecular Engineering, Johns Hopkins University
  • Rajesh Beri, Ph.D., Technical Director R&T, BioManufacturing, Lonza Biologics
  • Michael J. Tarlov, Ph.D., Chief, Biomolecular Measurement Division, NIST
  • Jean Hu-Primmer, M.S., Health Scientist and Senior Advisor for Continuous Manufacturing, Influenza Division, BARDA/ASPR
  • Kamal Rashid, Ph.D., Director and Research Professor, Biomanufacturing Education and Training Center, Worcester Polytechnic Institute
  • M. Nazmul Karim, Ph.D., Professor of Chemical Engineering, Texas A&M University
  • Abraham Lenhoff, Ph.D., Professor of Chemical Engineering, University of Delaware
  • Robert S. Gronke, Ph.D., Senior Principal Scientist, Biogen, Inc.
  • Steve Cramer, Ph.D., William Weightman Walker Professor of Chemical and Biological Engineering, Rensselaer Polytechnic Institute
  • Ruben Carbonell, Ph.D., Director, Biomanufacturing Training and Education Center (BTEC), NC State University
  • Michael Phillips, Ph.D., Director, Next Generation BioProcessing R&D, EMD Millipore
  • Rachel Kroe-Barrett, Ph.D., Immune Modulation and Biotherapeutics Discovery, Director, Biophysics, Boehringer Ingelheim Pharmaceuticals